222 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 222 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Oncology, Clinical, Therapeutic, Drug, Cancer, Tumor, Cell, Therapies, Immuno-Oncology .

Start-ups (40)

Early-stage companies (71)

Established companies (102)

The majority of these companies is located in the following countries.

United States (118)

United Kingdom (22)

China (15)

France (12)

Example Companies

Find companies in your area

F-star Biotechnology F-star Biotechnology Limited

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Press Releases - Events - Media - PIPELINE - Proprietary Pipeline - Immuno-oncology - Overview - Management Team - Board - Scientific Advisors - Overview ...

Pipeline - Immuno-oncology PIPELINE Home PIPELINE - Immuno-oncology - Proprietary Pipeline - Immuno-oncology Pipeline Immuno-oncology F-star’s Modular ...

is ideally suited to produce the next generation of immuno-oncology therapeutics. Immuno-oncology leverages the body’s natural immune response to fight ...

world-class scientific advisory team, we have selected a large number of immuno-oncology targets to which we are currently generating a large number of Fcabs

Press Releases - Events - Media - PIPELINE - Proprietary Pipeline - Immuno-oncology - Overview - Management Team - Board - Scientific Advisors - Overview ...

- Upcoming Events - Past Events - Media - Proprietary Pipeline - Immuno-oncology PIPELINE Home PIPELINE - Proprietary Pipeline Pipeline Proprietary ...

programmes Discovery IMMUNO-ONCOLOGY Multiple mAb² product candidates Multiple bispecific antibody product candidates in immuno-oncology. PRECLINICAL FS222 ...

FS222 PRECLINICAL IMMUNO-ONCOLOGY FS222 mAb² candidate FS222 is a potential best-in-class bispecific antibody candidate in immuno-oncology targeting CD137 ...

Agonist Bispecific Antibody Programmes (November 2018) FS120 PRECLINICAL IMMUNO-ONCOLOGY FS120 mAb² candidate FS120 is a potential best-in-class dual agonist ...

Bispecific Antibody Programmes (November 2018) PHASE 1 FS118 PHASE 1 IMMUNO-ONCOLOGY FS118 mAb² candidate Currently in a Phase 1 clinical trial at four

ALX Oncology ALX Oncology Limited

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway ...

About ALX Oncology ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies

Release Details ALX Oncology to Collaborate with Merck on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination with KEYTRUDA® ...

2020 (GLOBE NEWSWIRE) -- ALX Oncology (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway ...

About ALX OncologyALX Oncology is a publicly-traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies

NextCure NextCure, Inc

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Contact FIND-IOTM Functional, Integrated, NextCure Discovery in Immuno-Oncology (FIND-IOTM) Technology Our FIND-IO platform uses proprietary approaches ...

macrophage subpopulations and cancer cell lines. With our current focus in immuno oncology, we have identified several positive and negative immune regulators

Through its proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, NextCure studies various immune cells to discover

Harbour Biomed

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases August 24, 2020 Share to Facebook Share to ...

Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases August 24, 2020 Cambridge, MA, Rotterdam, ...

commercialize potential novel therapeutic molecules in the fields of Immuno-Oncology and infectious diseases. HBM will leverage its tools in next-generation ...

biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19. The company is building its proprietary

biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Our discovery and development programs are ...

biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Our discovery and development programs are ...

biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Our discovery and development programs are ...

biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Our discovery and development programs are

LIfT BioSciences

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

further investment rounds with institutional investors. “Whilst most immuno-oncology therapies, such as CAR-T cells and checkpoint inhibitors, are focused ...

BioSciences is a socially-minded biotech bringing to market a first-in-class immuno-oncology cell therapy called N-LIfT, under development to destroy all solid tumours

mass produced ‘cancer killing neutrophils’ to deliver a portfolio of immuno-oncology cell therapies for delivering complete remission in all solid tumours

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.